Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide and Prone Positioning for CSF Leak Prevention in Children
NCT01867268Phase 2Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide in cerebrospinal fluid leak, wound dehiscence, sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
acetazolamide
03
Conditions
cerebrospinal fluid leakwound dehiscence
Beyond the preview
Go deeper on NCT01867268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01867268.